We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+26.05%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$62.3B
AUM Growth
+$13.8B
(+28%)
Cap. Flow
+$3.01B
Cap. Flow
% of AUM
4.83%
Top 10 Holdings %
Top 10 Hldgs %
42.27%
Holding
775
New
54
Increased
269
Reduced
324
Closed
89
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$1.47B |
| 2 |
Boeing
BA
|
+$959M |
| 3 |
Walt Disney
DIS
|
+$896M |
| 4 |
Salesforce
CRM
|
+$633M |
| 5 |
Intuitive Surgical
ISRG
|
+$407M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$751M |
| 2 |
Procter & Gamble
PG
|
+$623M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$579M |
| 4 |
Merck
MRK
|
+$440M |
| 5 |
Yum China
YUMC
|
+$153M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.89% |
| 2 | Consumer Discretionary | 16.68% |
| 3 | Healthcare | 12.96% |
| 4 | Communication Services | 12.75% |
| 5 | Financials | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IPG
476
DELISTED
Interpublic Group of Companies
IPG
| $253K | ﹤0.01% |
14,734
-15,276
| -51% | -$252K |
|
477
Eaton
ETN
$173B
| $237K | ﹤0.01% |
2,709
-9,073
| -77% | -$747K |
|
478
Citigroup
C
$227B
| $228K | ﹤0.01% |
4,469
-12,122
| -73% | -$575K |
|
479
Iron Mountain
IRM
$36.2B
| $219K | ﹤0.01% |
8,381
-28,533
| -77% | -$721K |
|
480
Gilead Sciences
GILD
$165B
| $204K | ﹤0.01% |
2,649
+1,908
| +257% | +$146K |
|
481
iShares Russell 1000 Growth ETF
IWF
$127B
| $199K | ﹤0.01% |
4,156
-52,208
| -93% | -$2.3M |
|
482
Vipshop
VIPS
$7.4B
| $198K | ﹤0.01% |
9,956
| – | – |
|
483
Blackstone
BX
$113B
| $193K | ﹤0.01% |
3,410
-10,165
| -75% | -$535K |
|
|
CTRA
484
DELISTED
Coterra Energy
CTRA
| $174K | ﹤0.01% |
+10,139
| New | +$197K |
|
485
CoStar Group
CSGP
$12.8B
| $158K | ﹤0.01% |
2,230
+40
| +2% | +$2.59K |
|
486
ResMed
RMD
$31.9B
| $154K | ﹤0.01% |
805
+9
| +1% | +$1.47K |
|
|
WCN
487
Waste Connections
WCN
$41.9B
| $149K | ﹤0.01% |
1,589
+18
| +1% | +$1.6K |
|
|
QTS
488
DELISTED
QTS REALTY TRUST, INC.
QTS
| $149K | ﹤0.01% |
+2,318
| New | +$146K |
|
489
Global Payments
GPN
$22.8B
| $146K | ﹤0.01% |
862
+7
| +0.8% | +$1.17K |
|
|
SGEN
490
DELISTED
Seagen Inc. Common Stock
SGEN
| $144K | ﹤0.01% |
849
-130
| -13% | -$19.4K |
|
491
RingCentral
RNG
$5.38B
| $143K | ﹤0.01% |
500
-76
| -13% | -$19.2K |
|
492
DexCom
DXCM
$33.1B
| $142K | ﹤0.01% |
1,400
-508
| -27% | -$45.4K |
|
493
Akamai
AKAM
$16.9B
| $136K | ﹤0.01% |
1,267
+23
| +2% | +$2.31K |
|
494
Vertex Pharmaceuticals
VRTX
$133B
| $136K | ﹤0.01% |
467
-41
| -8% | -$11.1K |
|
|
SPLK
495
DELISTED
Splunk Inc
SPLK
| $135K | ﹤0.01% |
678
+12
| +2% | +$1.9K |
|
496
iShares S&P 500 Growth ETF
IVW
$77.4B
| $133K | ﹤0.01% |
2,568
| – | – |
|
497
Corpay
CPAY
$26.2B
| $130K | ﹤0.01% |
516
+9
| +2% | +$2.14K |
|
|
ANSS
498
DELISTED
Ansys
ANSS
| $127K | ﹤0.01% |
435
+8
| +2% | +$2.13K |
|
499
Exelon
EXC
$45.8B
| $118K | ﹤0.01% |
4,557
-834
| -15% | -$22.1K |
|
|
MXIM
500
DELISTED
Maxim Integrated Products
MXIM
| $118K | ﹤0.01% |
1,950
+264
| +16% | +$14.7K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2020 Portfolio in Review
As of Q2 2020, Loomis, Sayles & Company held 775 positions worth $62.3B, up 28% from $48.5B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Loomis, Sayles & Company deployed $3.01B of net new capital in Q2 2020, opening 54 new positions and adding to 269 existing holdings. Its largest new stake was Dropbox: 3,912,402 shares worth $85.2M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $751M trimmed.
- Loomis, Sayles & Company's largest Q2 2020 buy was Dropbox: 3,912,402 shares worth $85.2M.
- Loomis, Sayles & Company added most to Bank of America Series L in Q2 2020, an estimated $1.47B increase.
- Loomis, Sayles & Company's biggest Q2 2020 reduction was Amgen, cutting an estimated $751M.
- Loomis, Sayles & Company fully exited Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A in Q2 2020, selling an estimated $32.2M.
- Loomis, Sayles & Company's ten largest holdings make up 42% of its $62.3B portfolio in Q2 2020.
- Loomis, Sayles & Company opened 54 new positions and closed 89 in Q2 2020.
- Loomis, Sayles & Company's portfolio value rose 28% quarter-over-quarter to $62.3B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2020, filed 14 Aug 2020.